CD 3 and PRLR bispecific antibody and construction and application thereof
A bispecific antibody and antibody technology, applied in the direction of antibodies, specific peptides, anti-tumor drugs, etc., to achieve obvious effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] 1. Construction of expression vectors for fragment A and fragment B
[0054] The antibody proteins of fragment A and fragment B bind to CD3 and PRLR extracellular regions respectively, and the amino acid sequences of CD3 and PRLR extracellular regions are shown in Table 1. The expression vectors are respectively according to the antibody A protein structure ( figure 1 ), Fragment A protein consists of two heavy chains (CD3Hc and Int C Fc and a light chain (CD3Lc). Vectors corresponding to the three chains were designed separately. CD3 antibody variable region gene heavy chain and light chain sequence, the required gene segment is synthesized by gene chemistry, and the corresponding gene segments of CD3Hc and CD3Lc protein chains are assembled by PCR amplified oligonucleotide annealing connection, through the restriction site HindIII / BamH1 and other cloning expression vectors, expression vectors can choose mammalian cell expression vectors. In order to solve the hea...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com